You have accessRestricted access
A Postmarketing Surveillance Study on Erbitux (Cetuximab) in Patients With Metastatic Colorectal Cancer Refractory to Irinotecan-Containing Treatment
Wen-Tsung Huang, Hong-Hwa Chen, Chung-Hung Yeh, Yin-Che Lu, Wei-Shou Hwang, Jen-Seng Huang, Chou-Pin Chen, Peng-Chan Lin, Wu-Ching Uen, Yang-Cheng Lee, Hwei-Ming Wang, Hong-Cheng Wu, Jinn-Shiun Chen, Ruey-Ho Kao, Chi-Chou Huang, Hao-Hsuan Jeng, Chia-Jung Lin, Ruey-Kuen Hsieh
December 14, 61 (7) 1108-1114; DOI: 10.2310/JIM.0b013e3182a6799d